I have a feeling ResMed and RAP will make a deal happen. The results were actually slightly better than I thought. If ResMed give RAP a revenue stream it gives the market confidence there won't be another CR in the future, therefore, upward momentum won't be thwarted by a CR (a CR may never happen, just looking at different scenarios).
What's your thoughts on how RAP should approach the OSA side of the business? Whoever I missed below feel free to have your input...
@Red bar
@RNClarke
@MSIMaker
@wop
@AICp
@Deadant
@silverfox3731
- Forums
- ASX - By Stock
- RAP
- Ann: Positive Results from At-Home Sleep Apnoea Study
Ann: Positive Results from At-Home Sleep Apnoea Study, page-57
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online